Neurocrine Biosciences Inc
2021 Q2 - 2025 Q4 (17 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 8,923 | 0.0% | 62,913 | 12/31/2025 |
| 2025 Q1 | 5/14/2025 | 44,201 | 0.1% | 399,648 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 102,151 | 0.2% | 748,359 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 84,907 | 0.2% | 736,910 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 90,328 | 0.2% | 656,118 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 20,920 | 0.1% | 151,683 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 9,848 | 0.0% | 74,745 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 6,816 | 0.0% | 60,589 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 15,905 | 0.0% | 168,669 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 34,661 | 0.1% | 342,432 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 5,300 | 0.0% | 44,376 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 2,430 | 0.0% | 22,876 | 9/30/2022 |
| 2022 Q2 | 8/12/2022 | 220 | 0.0% | 2,253 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 2,322 | 0.0% | 24,769 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 1,530 | 0.0% | 17,969 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 1,848 | 0.0% | 19,269 | 9/30/2021 |
| 2021 Q2 | 8/13/2021 | 1,486 | 0.0% | 15,269 | 6/30/2021 |